Thermo Fisher Scientific Completes Acquisition of Finesse Solutions, Inc.
15 February 2017 - 10:15AM
Business Wire
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in
serving science, today completed its previously announced
acquisition of Finesse Solutions, Inc., a leader in the development
of scalable control automation systems and software for
bioproduction. The business will be integrated into Thermo Fisher’s
Life Sciences Solutions Segment. Terms of the transaction were not
disclosed.
Based in Santa Clara, California, Finesse Solutions is a leader
in bioprocess management technology, generating approximately $50
million in revenue in 2016. Its proprietary Smart™ technology,
which consists of sensors, controllers and software, is designed to
optimize the bioproduction workflow. The company has been a
technology partner of Thermo Fisher Scientific since 2013.
About Thermo Fisher ScientificThermo Fisher Scientific
Inc. (NYSE: TMO) is the world leader in serving science, with
revenues of $18 billion and more than 55,000 employees
globally. Our mission is to enable our customers to make the world
healthier, cleaner and safer. We help our customers accelerate life
sciences research, solve complex analytical challenges, improve
patient diagnostics and increase laboratory productivity. Through
our premier brands – Thermo Scientific, Applied Biosystems,
Invitrogen, Fisher Scientific and Unity Lab Services – we offer an
unmatched combination of innovative technologies, purchasing
convenience and comprehensive support. For more information, please
visit www.thermofisher.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170214006523/en/
Thermo Fisher ScientificMediaRon O’Brien,
781-622-1242ron.obrien@thermofisher.comwww.thermofisher.comorInvestorsKen
Apicerno, 781-622-1294ken.apicerno@thermofisher.com
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2024 to May 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From May 2023 to May 2024